Question 1

Am I eligible to participate in this study based on my vaccination history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment clinical trial (NCT05119738). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this trial help improve my protection against COVID-19?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment clinical trial (NCT05119738). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks or side effects of receiving a third dose?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment clinical trial (NCT05119738). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the study site, and what will those visits involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment clinical trial (NCT05119738). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects after receiving the vaccine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment clinical trial (NCT05119738). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my participation in this study affect my ongoing cancer treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment clinical trial (NCT05119738). Contact the study team or your healthcare provider for specific answers.

What this study is about